Clinical Physiology of Circulation

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Cardiac arrhythmias as risk factors of in-stent restenosis

Authors: Vachev A.N., Germanov V.A.

Company:
Samara State Medical University, Samara, 443099, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

DOI: https://doi.org/10.24022/1814-6910-2020-17-4-308-312

UDC: 616.12-008.318

Link: Clinical Physiology of Blood Circulaiton. 2020; 4 (17): 308-312

Quote as: Vachev A.N., Germanov V.A. Cardiac arrhythmias as risk factors of in-stent restenosis. Clinical Physiology of Circulation. 2020; 17 (4): 308–12 (in Russ.). DOI: 10.24022/1814-6910-2020-17-4-308-312

Received / Accepted:  10.09.2020 / 17.09.2020

Full text:  

Abstract

Objective. To study the influence of cardiac arrhythmias on in-stent restenosis development after urgent percutaneous coronary intervention at patients with acute coronary syndrome (ACS).

Material and methods. The study included 223 patients who had undergone coronary stenting with bare metal stents for ACS and who required subsequent coronary angiography during follow-up period. All the patients were divided into two groups: with in-stent restenosis over 50% and with in-stent restenosis less than 50% or without restenosis. Patients inclurestenosis as well as cardiac arrhythmias.

Results. Haemodynamically significant restenosis over 50% occurred much more frequently at patients with early ventricular extrasystoles over 3000 per day (RR 5.396, p < 0.001) and atrial fibrillation with long pauses over 2 seconds between ventricular contractions (RR 2.984, p < 0.001), considering that other common risk factors of restenosis didn't differ significantly between 2 groups.

Conclusion. Higher risk of in-stent restenosis development at patients with early ventricular extrasystoles over 3000 per day and atrial fibrillation with long pauses between ventricular contractions can be coupled with additional trauma of arterial wall enhancing negative influence of local risk factors. That is why we consider it reasonable to purposefully reveal the above mentioned arrhythmias at patients after urgent coronary stenting with subsequent antiarrhythmic therapy and coronary angiography between 6–12 months after intervention for early restenosis recognition.

References

  1. Ibanez B., James S., Agewall S., Antunes M.J., Bucciarelli-Ducci C., Bueno H. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 2017; 39 (2): 119–77. DOI: 10.1093/eurheartj/ehx393
  2. Buccheri D., Piraino D., Andolina G., Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J. Thorac. Dis. 2016; 8 (10): E1150–E1162. DOI: 10.21037/jtd.2016.10.93
  3. Tsigkas G.G., Karantalis V., Hahalis G., Alexopoulos D. Stent restenosis, pathophysiology and treatment options: a 2010 update. Hellenic. J. Cardiol. 2011; 52 (2): 149–57. DOI: 10.1080/17482940701263285
  4. Roffi M., Patrono C., Collet J., Mueller C., Valgimigli M., Andreotti F. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 2015; 37 (3): 267–315. DOI: 10.1093/eurheartj/ehv320
  5. Алекян Б.Г., Абросимов А.В. Современное состояние рентгенэндоваскулярного лечения острого коронарного синдрома и перспективы его развития в Российской Федерации. Комплексные проблемы сердечно-сосудистых заболеваний. 2013; 1: 5–9. DOI: 10.17802/2306-1278-2013-1-5-9
  6. Looser P., Kim L., Feldman D. In-stent restenosis: pathophysiology and treatment. Curr. Treat. Options. Cardiovasc. Med. 2016; 18 (2). DOI: 10.1007/s11936- 015-0433-7
  7. Бокерия Л.А., Алекян Б.Г., Анри М. Рентгеноэндоваскулярная хирургия ишемической болезни сердца. В кн.: Руководство по рентгеноэндоваскулярной хирургии сердца и сосудов. В 3-х т. Т. 3. М.: НЦССХ им. А.Н. Бакулева; 2008.
  8. Pleva L., Kukla P., Hlinomaz O. Treatment of coronary in-stent restenosis: a systematic review. J. Geriatr. Cardiol. 2018; 15 (2): 173–84. DOI: 10.11909/j.issn.1671-5411.2018.02.007
  9. Wu Y., Fu X. Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drugeluting stents implantation. J. Clin. Lab. Anal. 2019; 33 (2): e22666. DOI: 10.1002/jcla.22666
  10. Cho J.Y. Identification of risk factors influencing instent restenosis with acute coronary syndrome presentation. Chonnam. Med. J. 2017; 53 (3): 203–10. DOI: 10.4068/cmj.2017.53.3.203
  11. Corti R., Fuster V., Badimon J.J., Hutter R., Fayad Z.A. New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo. Ann. N. Y. Acad. Sci. 2001; 947: 181–98. DOI: 10.1111/j.1749-6632.2001.tb03940.x
  12. Kinlay S., Libby P., Ganz P. Endothelial function and coronary artery disease. Curr. Opin. Lipidol. 2001; 12 (4): 383–9. DOI: 10.1097/00041433-200108000-00003
  13. Pal N., Din J., O'Kane P. Contemporary management of stent failure: part one. Interv. Cardiol. 2019; 14 (1): 10–6. DOI: 10.15420/icr.2018.39.1
  14. Alraies M.C., Darmoch F., Tummala R., Waksman R. Diagnosis and management challenges of in-stent restenosis in coronary arteries. World J. Cardiol. 2017; 9 (8): 640–51. DOI: 10.4330/wjc.v9.i8.640
  15. Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L. et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2016; 37 (29): 2315–81. DOI: 10.1093/eurheartj/ehw106
  16. Германова О.А., Германов А.В., Германов В.А., Терешина О.В., Пискунов М.В. Анатомо-функциональный анализ роли экстрасистолии как фактора риска развития атеросклероза. Морфологические ведомости. 2018; 26 (4): 11–4. DOI: 10.20340/mv-mn. 18(26).04.11-14
  17. Бисярина В.П., Яковлев В.М., Кукса П.Я. Артериальные сосуды и возраст. М.: Медицина; 1986.
****
  1. Ibanez B., James S., Agewall S., Antunes M.J., Bucciarelli-Ducci C., Bueno H. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 2017; 39 (2): 119–77. DOI: 10.1093/eurheartj/ehx393
  2. Buccheri D., Piraino D., Andolina G., Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J. Thorac. Dis. 2016; 8 (10): E1150–E1162. DOI: 10.21037/jtd.2016.10.93
  3. Tsigkas G.G., Karantalis V., Hahalis G., Alexopoulos D. Stent restenosis, pathophysiology and treatment options: a 2010 update. Hellenic. J. Cardiol. 2011; 52 (2): 149–57. DOI: 10.1080/17482940701263285
  4. Roffi M., Patrono C., Collet J., Mueller C., Valgimigli M., Andreotti F. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 2015; 37 (3): 267–315. DOI: 10.1093/eurheartj/ehv320
  5. Alekyan B.G., Abrosimov A.V. The current situation and future of the percutaneous coronary intervention for acute coronary syndrom in Russian Federation. Complex Issues of Cardiovascular Diseases. 2013; 1: 5–9 (in Russ.). DOI: 10.17802/2306-1278-2013-1-5-9
  6. Looser P., Kim L., Feldman D. In-stent restenosis: pathophysiology and treatment. Curr. Treat. Options. Cardiovasc. Med. 2016; 18 (2). DOI: 10.1007/s11936- 015-0433-7
  7. Bockeria L.A., Alekyan B.G., Anri M. Endovascular surgery of ischemic heart disease. In: Guidelines for endovascular surgery of the heart and blood vessels. 3rd ed. Vol. 3. Moscow; 2008 (in Russ.)
  8. Pleva L., Kukla P., Hlinomaz O. Treatment of coronary in-stent restenosis: a systematic review. J. Geriatr. Cardiol. 2018; 15 (2): 173–84. DOI: 10.11909/j.issn.1671-5411.2018.02.007
  9. Wu Y., Fu X. Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drugeluting stents implantation. J. Clin. Lab. Anal. 2019; 33 (2): e22666. DOI: 10.1002/jcla.22666
  10. Cho J.Y. Identification of risk factors influencing instent restenosis with acute coronary syndrome presentation. Chonnam. Med. J. 2017; 53 (3): 203–10. DOI: 10.4068/cmj.2017.53.3.203
  11. Corti R., Fuster V., Badimon J.J., Hutter R., Fayad Z.A. New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo. Ann. N. Y. Acad. Sci. 2001; 947: 181–98. DOI: 10.1111/j.1749-6632.2001.tb03940.x
  12. Kinlay S., Libby P., Ganz P. Endothelial function and coronary artery disease. Curr. Opin. Lipidol. 2001; 12 (4): 383–9. DOI: 10.1097/00041433-200108000-00003
  13. Pal N., Din J., O'Kane P. Contemporary management of stent failure: part one. Interv. Cardiol. 2019; 14 (1): 10–6. DOI: 10.15420/icr.2018.39.1
  14. Alraies M.C., Darmoch F., Tummala R., Waksman R. Diagnosis and management challenges of in-stent restenosis in coronary arteries. World J. Cardiol. 2017; 9 (8): 640–51. DOI: 10.4330/wjc.v9.i8.640
  15. Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L. et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2016; 37 (29): 2315–81. DOI: 10.1093/eurheartj/ehw106
  16. Germanova O.A., Germanov A.V., Germanov V.A., Tereshina O.V., Piskunov M.V. The anatomo-functional analysis of the role of the extrasistoly as a predictor of the development of the atherosclerosis. Morphological Newsletter. 2018; 26 (4): 11–4 (in Russ.). DOI: 10.20340/mv-mn.18(26).04.11-14
  17. Bisyarina V.P., Yakovlev V.M., Kuksa P.Ya. Arterial vessels and age. Moscow: Meditsina; 1986 (in Russ.).]

About Authors

  • Aleksey N. Vachev, Dr. Med. Sc., Professor, Chief of Faculty Surgery Chair; ORCID
  • Vladimir A. Germanov, Postgraduate; ORCID

 If you found mistakes, select text and press Alt+A